S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: GENETIC: comparative genomic hybridization|GENETIC: microarray analysis|GENETIC: reverse transcriptase-polymerase chain reaction|OTHER: diagnostic laboratory biomarker analysis
Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)